p24CE1/2 pDNA vaccine
Sponsors
National Institute of Allergy and Infectious Diseases (NIAID)
Conditions
HIV Infections
Phase 1
Safety and Immunogenicity of pDNA Vaccines Expressing HIV M Group p24^Gag Conserved Elements and/or p55^Gag, Administered With IL-12 pDNA
CompletedNCT03181789
Start: 2017-10-18End: 2020-04-29Updated: 2024-02-07
HIV-1-Gag Conserved-Element DNA Vaccine (p24CE) Vaccine Study
CompletedNCT03560258
Start: 2019-03-26End: 2021-02-10Updated: 2022-04-26